[1]
S. Rekha, “Synthesis, Spectroscopic Characterization (FT-IR, FT-Raman and NMR) and in vitro Anticancer Activity of (E)-5-Bromo-3-((4-chloro-3-(trifluoromethyl)phenyl)imino)indolin-2-one”, ajc, vol. 37, no. 8, pp. 2059–2071, Jul. 2025.